Botulinum Toxin in Nonachalasia Motility Disorders: A Welcomed Therapy in an Area With Limited Therapeutic Options

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1122-1124

  Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

DYSPHAGIA; EDITORIAL; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS SPASM; GASTROINTESTINAL MOTILITY DISORDER; HEARTBURN; HUMAN; NONACHALASIA MOTILITY DISORDER; NUTCRACKER ESOPHAGUS; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORAX PAIN; WEIGHT REDUCTION;

BOTULINUM TOXINS; DEGLUTITION DISORDERS; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGEAL SPASM, DIFFUSE; FEMALE; HUMANS; MALE;

EID: 84882855768     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.04.009     Document Type: Editorial

References (20)

1. Vanuytsel T., Bisschops R., Farré R., et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013, 11:1115-1121.
2. Vaezi M.F., Richter J.E. Diagnosis and management of achalasia. Am J Gastroenterol 1999, 94:3406-3412. American College of Gastroenterology Practice Parameter Committee.
3. Vaezi M.F., Richter J.E. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998, 27:21-35.
4. Vaezi M.F., Richter J.E., Wilcox C.M., et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999, 44:231-239.
5. Spechler S.J., Castell D.O. Classification of oesophageal motility abnormalities. Gut 2001, 49:145-151.
6. Bredenoord A.J., Fox M., Kahrilas P.J., et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012, 24(Suppl 1):57-65.
7. Roman S., Pandolfino J.E., Chen J., et al. Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT). Am J Gastroenterol 2012, 107:37-45.
8. Carlson D.A., Pandolfino J.E. High-resolution manometry and esophageal pressure topography: filling the gaps of convention manometry. Gastroenterol Clin North Am 2013, 42:1-15.
9. Nicodème F., de Ruigh A., Xiao Y., et al. A comparison of symptom severity and bolus retention with Chicago classification esophageal pressure topography metrics in patients with achalasia. Clin Gastroenterol Hepatol 2013, 11:131-137. quiz e15.
10. Pandolfino J.E., Kahrilas P.J. Perspectives in clinical gastroenterology and hepatology presentation, diagnosis and management of achalasia. Clin Gastroenterol Hepatol 2013, 11:887-897.
11. Roman S., Kahrilas P.J., Boris L., et al. High-resolution manometry studies are frequently imperfect but usually still interpretable. Clin Gastroenterol Hepatol 2011, 9:1050-1055.
12. Pandolfino J.E., Kwiatek M.A., Nealis T., et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008, 135:1526-1533.
13. Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977, 72:23-27.
14. Kikendall J.W., Mellow M.H. Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility. Gastroenterology 1980, 79:703-706.
15. Cattau E.L., Castell D.O., Johnson D.A., et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991, 86:272-276.
16. Drenth J.P., Bos L.P., Engels L.G. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990, 4:411-416.
17. Clouse R.E., Lustman P.J., Eckert T.C., et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987, 92:1027-1036.
18. Cannon R.O., Quyyumi A.A., Mincemoyer R., et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330:1411-1417.
19. Nayar D.S., Khandwala F., Achkar E., et al. Esophageal manometry: assessment of interpreter consistency. Clin Gastroenterol Hepatol 2005, 3:218-224.
20. Storr M., Allescher H.D., Rösch T., et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injection of botulinum toxin: a prospective study with long term follow-up. Gastrointest Endosc 2001, 54:18A.